Jon Cuthbert

Bitcoin’s market value has fallen to about US$1.46 trillion, placing the cryptocurrency below several major technology companies and commodities in global asset rankings.

Kraken plans to launch the first CFTC-regulated perpetual futures contracts in the United States within the next 30 days, giving eligible traders domestic access to one of the most widely used products in global crypto derivatives markets.

U.S. Treasury bonds advanced while the U.S. Dollar Index slipped to an intraday low of 98.8, highlighting a renewed preference for safe-haven assets as investors reassessed the outlook for interest rates and economic growth.

The United States has designated Brazil’s two largest criminal organisations, Comando Vermelho (CV) and Primeiro Comando da Capital (PCC), as Specially Designated Global Terrorists, with plans to classify them as Foreign Terrorist Organisations from June 5.

An anonymous Bitcoin user has inscribed the full text of the United States Constitution onto the Bitcoin blockchain, creating a permanent on-chain record of one of America's most important historical documents.

JPMorgan chief executive Jamie Dimon warned that the latest version of the CLARITY Act could ultimately fail unless lawmakers revise provisions governing stablecoin rewards.

The Bank of Nova Scotia (Scotiabank) (NYSE:BNS) has signed a definitive agreement to acquire Maple Financial Holdings, the parent company of MapleMark Bank, a U.S. commercial bank based in Dallas, Texas. Financial terms of the transaction were not immediately disclosed.

Bristol Myers Squibb (NYSE:BMY) announced positive late-breaking results from its Phase 3 SUCCESSOR-2 clinical trial, demonstrating that its experimental oral therapy mezigdomide significantly extends the time patients with relapsed or refractory multiple myeloma live without their disease worsening.

Agios Pharmaceuticals (NASDAQ:AGIO) announced that it will discontinue the clinical development of its investigational oral therapy tebapivat for lower-risk myelodysplastic syndromes (LR-MDS) after a Phase 2b study failed to meet its predefined threshold for advancement.

Chagee Holdings (NASDAQ:CHA) reported a rise in first-quarter revenue as aggressive international expansion partially offset cooling demand in its home market, though a sharp contraction in operating margins drove net income down by more than a third.